{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T12:40:52Z","timestamp":1688042452977},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00104-023-01878-x","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T15:01:41Z","timestamp":1683212501000},"page":"602-607","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aktuelle Indikation und operative Strategie beim renalen Hyperparathyreoidismus","Current indications and operative strategy for renal hyperparathyroidism"],"prefix":"10.1007","volume":"94","author":[{"given":"Julia I.","family":"Staubitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Musholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"1878_CR1","unstructured":"DESTATIS (2022) https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Gesundheit\/Krankenhaeuser\/Tabellen\/drg-operationen-insgesamt.html. Zugegriffen: 12. Okt. 2022"},{"issue":"3","key":"1878_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00423-021-02173-1","volume":"406","author":"T Weber","year":"2021","unstructured":"Weber\u00a0T et\u00a0al (2021) Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK). Langenbecks Arch Surg 406(3):571\u2013585","journal-title":"Langenbecks Arch Surg"},{"issue":"7120","key":"1878_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa\u00a0I et\u00a0al (2006) Klotho converts canonical FGF receptor into a\u00a0specific receptor for FGF23. Nature 444(7120):770\u2013774","journal-title":"Nature"},{"issue":"12","key":"1878_CR4","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova\u00a0T et\u00a0al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79(12):1370\u20131378","journal-title":"Kidney Int"},{"issue":"7","key":"1878_CR5","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez\u00a0O et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J\u00a0Am Soc Nephrol 16(7):2205\u20132215","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1878_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1172\/JCI116720","volume":"92","author":"N Fukuda","year":"1993","unstructured":"Fukuda\u00a0N et al (1993) Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a\u00a0more severe form of parathyroid hyperplasia in chronic uremic patients. J\u00a0Clin Invest 92(3):1436\u20131443","journal-title":"J Clin Invest"},{"issue":"5","key":"1878_CR7","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/j.1523-1755.2000.00370.x","volume":"58","author":"S Yano","year":"2000","unstructured":"Yano\u00a0S et al (2000) Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58(5):1980\u20131986","journal-title":"Kidney Int"},{"issue":"36","key":"1878_CR8","doi-asserted-by":"publisher","first-page":"18632","DOI":"10.1074\/jbc.M116.744052","volume":"291","author":"WB Sneddon","year":"2016","unstructured":"Sneddon\u00a0WB et al (2016) Convergent signaling pathways regulate parathyroid hormone and fibroblast growth factor-23 action on NPT2A-mediated phosphate transport. J\u00a0Biol Chem 291(36):18632\u201318642","journal-title":"J Biol Chem"},{"issue":"6","key":"1878_CR9","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1681\/ASN.2016080828","volume":"28","author":"DA Drew","year":"2017","unstructured":"Drew\u00a0DA et\u00a0al (2017) Association between soluble klotho and change in kidney function: the health aging and body composition study. J\u00a0Am Soc Nephrol 28(6):1859\u20131866","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1878_CR10","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/ERC-19-0284","volume":"27","author":"M Almquist","year":"2020","unstructured":"Almquist\u00a0M, Isaksson\u00a0E, Clyne\u00a0N (2020) The treatment of renal hyperparathyroidism. Endocr Relat Cancer 27(1):R21\u2013r34","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"1878_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","volume":"58","author":"MJ Budoff","year":"2011","unstructured":"Budoff\u00a0MJ et\u00a0al (2011) Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 58(4):519\u2013526","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1878_CR12","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1681\/ASN.2007070760","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew\u00a0S et\u00a0al (2008) The mechanism of phosphorus as a\u00a0cardiovascular risk factor in CKD. J\u00a0Am Soc Nephrol 19(6):1092\u20131105","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1878_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","volume":"60","author":"AR Mazhar","year":"2001","unstructured":"Mazhar\u00a0AR et al (2001) Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60(1):324\u2013332","journal-title":"Kidney Int"},{"key":"1878_CR14","volume-title":"Nephrologie","author":"KU Alscher","year":"2015","unstructured":"Alscher\u00a0KU, B\u00f6hler\u00a0J, Luft\u00a0FC, Kunzendorf\u00a0U (2015) Nephrologie. Thieme, Stuttgart"},{"issue":"2","key":"1878_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2215\/CJN.06800615","volume":"11","author":"L Patel","year":"2016","unstructured":"Patel\u00a0L, Bernard\u00a0LM, Elder\u00a0GJ (2016) Sevelamer versus calcium-based binders for treatment of Hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials. Clin J Am Soc Nephrol 11(2):232\u2013244","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1878_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler\u00a0M et al (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and Bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336","journal-title":"Kidney Int"},{"issue":"8","key":"1878_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00423-015-1344-5","volume":"400","author":"K Lorenz","year":"2015","unstructured":"Lorenz\u00a0K et\u00a0al (2015) Surgical management of secondary hyperparathyroidism in chronic kidney disease\u2014a consensus report of the European Society of Endocrine Surgeons. Langenbecks Arch Surg 400(8):907\u2013927","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"1878_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.surg.2018.04.090","volume":"165","author":"BM Finnerty","year":"2019","unstructured":"Finnerty\u00a0BM et\u00a0al (2019) Parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery 165(1):129\u2013134","journal-title":"Surgery"},{"issue":"4","key":"1878_CR19","first-page":"1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1\u2013201","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1878_CR20","first-page":"1","volume":"11","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (113):S1\u2013130","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"1878_CR21","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1097\/SLA.0000000000005522","volume":"276","author":"S Dream","year":"2022","unstructured":"Dream\u00a0S et\u00a0al (2022) The American association of endocrine surgeons guidelines for the definitive surgical management of secondary and tertiary renal Hyperparathyroidism. Ann Surg 276(3):e141\u2013e176","journal-title":"Ann Surg"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-023-01878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-023-01878-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-023-01878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T12:02:39Z","timestamp":1688040159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-023-01878-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1007\/s00104-023-01878-x","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"value":"2731-6971","type":"print"},{"value":"2731-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"assertion":[{"value":"5 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.I.\u00a0Staubitz und T.J.\u00a0Musholt geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}